364. LATE-ONSET NEUTROPENIA IN PATIENTS UNDERGOING RITUXIMAB-INDUCED CONTINUOUS B CELL DEPLETION FOR AUTOIMMUNE DISEASE: DATA FROM A 738 PATIENT COHORT AND APPROACH TO MANAGEMENT